Filing search / Current reports / Madrigal Pharmaceuticals, Inc. / Page 8

8-K

kotgt9 yjnky03w931t

15 Jun 11

Entry into a Material Definitive Agreement

12:00am

8-K

xtncxun9b t1f

6 Jun 11

Submission of Matters to a Vote of Security Holders

12:00am

8-K

rvuvr5dm zqlap

22 Apr 11

Entry into a Material Definitive Agreement

12:00am

8-K

60df9s9vmlh808

15 Apr 11

Entry into a Material Definitive Agreement

12:00am

8-K

143iyew3mgqvmh

4 Apr 11

Other Events

12:00am

8-K

594iyb6562shhg

1 Mar 11

Other Events

12:00am

8-K

rbb56sr4sw2x5

9 Feb 11

Entry into a Material Definitive Agreement

12:00am

8-K

az02lwyxb1 vtlsrbm

14 Jan 11

Other Events

12:00am

8-K

f5t08j

12 Nov 10

Entry into a Material Definitive Agreement

12:00am

8-K

7j80ua07xt a8

5 Oct 10

Entry into a Material Definitive Agreement

12:00am

8-K

7ac9fr

5 Oct 10

Entry into a Material Definitive Agreement

12:00am

8-K

hqv0v icc

30 Sep 10

Synta Pharmaceuticals Appoints Donald Kufe, M.D. to Board of Directors

12:00am

8-K

6anlj2dug5eue

15 Sep 10

Synta Announces Expansion of Phase 2 Trial for STA-9090 in Non-Small Cell Lung Cancer Based on Encouraging Clinical Activity

12:00am

8-K

icugxwuyzd

31 Aug 10

Departure of Directors or Certain Officers

12:00am

8-K

w98ctpfoalsb1a 76t1

21 Jun 10

Departure of Directors or Certain Officers

12:00am

8-K

8f7hv yre

11 Feb 10

Entry into a Material Definitive Agreement

12:00am

8-K

bebkxo

8 Jan 10

Synta Pharmaceuticals Prices $25 Million Public Offering of Common Stock

12:00am

8-K

uecm15v89bo

27 Oct 09

Departure of Directors or Certain Officers

12:00am

8-K

txnu4okdwkp7

13 Jul 09

Other Events

12:00am

8-K

7wtls0 qgop1

19 Jun 09

Synta Pharmaceuticals Names Vojo Vukovic, M.D., Ph.D. Senior Vice President

12:00am